EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma

Daqi Jia, Peng Wang, Shiqi Zheng, Zi Lei, Wenmang Xu, Yuanyuan Wang, Xinyan Pan, Qiang Feng, Julun Yang

Translational Oncology · 2025-11 · 61 · 102525

DOI: 10.1016/j.tranon.2025.102525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2025-11. Verfasst von Daqi Jia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yunnan Provincial Science and Technology Department, Applied Basic Research Foundation of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ETV4Escape of immunityKRAS mutationsNSCLCPD-L1

Autor:innen und Institutionen

  • Department of Pathology, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan, China.
  • Department of Pathology, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan, China. Electronic address: feiniaonanfei@163.com.
  • Department of Pathology, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan, China. Electronic address: yangjulun@sina.com.

Förderung

  • Yunnan Provincial Science and Technology Department
  • Applied Basic Research Foundation of Yunnan Province

Zitieren

APA

Jia, D., Wang, P., Zheng, S., Lei, Z., Xu, W., Wang, Y., Pan, X., Feng, Q., & Yang, J. (2025). KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma. Translational Oncology, 61, 102525. https://doi.org/10.1016/j.tranon.2025.102525

Vancouver

Jia D, Wang P, Zheng S, Lei Z, Xu W, Wang Y, et al. KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma. Translational Oncology. 2025;61:102525. doi:10.1016/j.tranon.2025.102525

BibTeX
@article{Jia2025,
  author = {Jia, Daqi and Wang, Peng and Zheng, Shiqi and Lei, Zi and Xu, Wenmang and Wang, Yuanyuan and Pan, Xinyan and Feng, Qiang and Yang, Julun},
  title = {KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma},
  journal = {Translational Oncology},
  year = {2025},
  volume = {61},
  pages = {102525},
  doi = {10.1016/j.tranon.2025.102525}
}
Kostenlos starten →